XML 50 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Note 11 - Stockholders' Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

2022

  

2021

 

Dividend yield

  0.0%  0.0%

Expected volatility

  86.3%  86.6%

Risk-free interest rate

  1.9%  0.8%

Expected life in years

  5.56   5.82 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

For the Year Ended

 
  

December 31,

 
  

2022

  

2021

  

2020

 
             

Stock-based compensation:

            

Options:

            

Selling, general, and administrative

 $2,993  $3,873  $3,937 

Research and development

  553   573   3,018 

Restricted stock units:

            

Selling, general, and administrative

  5,054   8,239   13,841 

Research and development

  3,227   6,361   15,779 

Warrant modification:

            

Selling, general, and administrative

     13,587    

Total stock-based compensation expense

 $11,826  $32,633  $36,575 
Share-Based Payment Arrangement, Activity [Table Text Block]
  

Shares

  

Weighted Average Exercise Price

  

Weighted Average Remaining Contractual Term (years)

  

Aggregate Intrinsic Value (in thousands)

 

Outstanding at December 31, 2020

  5,009,342  $71.42   5.1  $3,458 

Granted

  640,748  $11.12   8.2    

Forfeited

  (186,339) $10.60       

Expired

  (868,504) $87.55       

Outstanding at December 31, 2021

  4,595,247  $62.43   4.5    

Granted

  582,353  $2.43   9.2    

Expired

  (965,119) $38.63       

Outstanding at December 31, 2022

  4,212,481  $59.59   5.1  $1,046 

Nonvested at December 31, 2022

  799,376  $5.95   8.8  $817 

Exercisable

  3,413,105  $72.15   4.3  $229 
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]
  

Shares

  

Weighted Average Grant-Date Fair Value

 

Nonvested shares at December 31, 2020

  899,672  $8.71 

Granted

  640,748  $7.90 

Vested/Issued

  (518,784) $9.51 

Forfeited

  (186,339) $7.96 

Nonvested shares at December 31, 2021

  835,297  $7.76 

Granted

  582,353  $1.72 

Vested

  (618,274) $6.61 

Nonvested shares at December 31, 2022

  799,376  $4.25 
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
  

Shares

  

Weighted Average Grant-Date Fair Value

 

Nonvested shares at December 31, 2020

  1,854,205  $13.51 

Granted

  1,409,733  $11.44 

Vested/Issued

  (1,089,120) $14.99 

Forfeited

  (775,501) $12.13 

Nonvested shares at December 31, 2021

  1,399,317  $11.03 

Granted

  1,382,811  $2.49 

Vested

  (1,017,744) $9.39 

Forfeited

  (262,617) $7.40 

Nonvested shares at December 31, 2022

  1,501,767  $4.92 
Warrant [Member]  
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

Dividend yield

  0.0%

Expected volatility

  87.0%

Risk-free interest rate

  0.8%

Expected life in years

  5.31